Literature DB >> 26888997

Antibiotic-associated encephalopathy.

Shamik Bhattacharyya1, R Ryan Darby2, Pooja Raibagkar2, L Nicolas Gonzalez Castro2, Aaron L Berkowitz2.   

Abstract

Delirium is a common and costly complication of hospitalization. Although medications are a known cause of delirium, antibiotics are an underrecognized class of medications associated with delirium. In this article, we comprehensively review the clinical, radiologic, and electrophysiologic features of antibiotic-associated encephalopathy (AAE). AAE can be divided into 3 unique clinical phenotypes: encephalopathy commonly accompanied by seizures or myoclonus arising within days after antibiotic administration (caused by cephalosporins and penicillin); encephalopathy characterized by psychosis arising within days of antibiotic administration (caused by quinolones, macrolides, and procaine penicillin); and encephalopathy accompanied by cerebellar signs and MRI abnormalities emerging weeks after initiation of antibiotics (caused by metronidazole). We correlate these 3 clinical phenotypes with underlying pathophysiologic mechanisms of antibiotic neurotoxicity. Familiarity with these types of antibiotic toxicity can improve timely diagnosis of AAE and prompt antibiotic discontinuation, reducing the time patients spend in the delirious state.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26888997     DOI: 10.1212/WNL.0000000000002455

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  52 in total

1.  Metronidazole-induced encephalopathy: a systematic review.

Authors:  Caspar Godthaab Sørensen; William Kristian Karlsson; Faisal Mohammad Amin; Mette Lindelof
Journal:  J Neurol       Date:  2018-12-07       Impact factor: 4.849

2.  Defining metronidazole-induced encephalopathy.

Authors:  Akira Kuriyama; Jeffrey L Jackson
Journal:  J Neurol       Date:  2019-03-12       Impact factor: 4.849

3.  Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling.

Authors:  Edyta K Bichler; Courtney C Elder; Paul S García
Journal:  J Neurophysiol       Date:  2016-10-12       Impact factor: 2.714

4.  Acute Kidney Injury as a Risk Factor for Delirium and Coma during Critical Illness.

Authors:  Edward D Siew; William H Fissell; Christina M Tripp; Jeffrey D Blume; Matthew D Wilson; Amanda J Clark; Andrew J Vincz; E Wesley Ely; Pratik P Pandharipande; Timothy D Girard
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

Review 5.  Neurologic Complications of Infective Endocarditis: Recent Findings.

Authors:  Marie Cantier; Mikael Mazighi; Isabelle Klein; J P Desilles; Michel Wolff; J F Timsit; Romain Sonneville
Journal:  Curr Infect Dis Rep       Date:  2017-09-19       Impact factor: 3.725

6.  Neurological and Psychiatric Adverse Effects of Antimicrobials.

Authors:  Madison K Bangert; Rodrigo Hasbun
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

7.  Potentially modifiable factors contributing to sepsis-associated encephalopathy.

Authors:  Romain Sonneville; Etienne de Montmollin; Julien Poujade; Maïté Garrouste-Orgeas; Bertrand Souweine; Michael Darmon; Eric Mariotte; Laurent Argaud; François Barbier; Dany Goldgran-Toledano; Guillaume Marcotte; Anne-Sylvie Dumenil; Samir Jamali; Guillaume Lacave; Stéphane Ruckly; Bruno Mourvillier; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440

8.  Ceftaroline-associated Encephalopathy in Patients With Severe Renal Impairment.

Authors:  Thomas C S Martin; Sean Chow; Scott T Johns; Sanjay R Mehta
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

9.  The First Case Report of Mediastinal Abscess Caused by Gemella bergeri.

Authors:  Hirokazu Toyoshima; Koji Fujii; Motoaki Tanigawa; Akiko Nakamura; Masaki Tanabe; Hiroyuki Tanaka; Yuki Nakanishi; Shigetoshi Sakabe
Journal:  Intern Med       Date:  2020-12-29       Impact factor: 1.271

10.  Attention-deficit/hyperactivity disorder medication and seizures.

Authors:  Kelsey K Wiggs; Zheng Chang; Patrick D Quinn; Kwan Hur; Robert Gibbons; David Dunn; Isabell Brikell; Henrik Larsson; Brian M D'Onofrio
Journal:  Neurology       Date:  2018-02-23       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.